Diaceutics (DXRX)

Sector:

Health Care

Index:

FTSE AIM All-Share

120.00p
   
  • Change Today:
    -0.50p
  • 52 Week High: 134.00
  • 52 Week Low: 84.50
  • Currency: UK Pounds
  • Shares Issued: 84.77m
  • Volume: 41,899
  • Market Cap: £101.73m
  • RiskGrade: 196
  • Beta: 0.15

Diaceutics strikes two new enterprise-wide agreements

By Iain Gilbert

Date: Thursday 16 May 2024

LONDON (ShareCast) - (Sharecast News) - Technology and solutions provider Diaceutics has struck two new enterprise-wide agreements, taking the total number to six engagements, across 29 separate therapeutic brands.
Diaceutics said on Thursday that these enterprise-wide engagements demonstrated the "successful execution" of its strategy to offer more products and services to existing customers.

Enterprise-wide engagements currently represent annual recurring revenues of £9.0m, £2.5m of which relates to the two additional engagements announced today, making up "a significant proportion of group ARR".

The AIM-listed group added that in addition to the two new engagements announced today, its largest existing enterprise-wide customer had recently extended the term of its enterprise-wide engagement through the end of 2026.

Chief executive Ryan Keeling said: "The strength of our growing pipeline of new enterprise-level contracts highlights the progress we are making in becoming the primary commercialisation partner for pharma and biotech companies launching new precision medicines, validating the accelerated investment in our platform technology.

"These new engagements represent a significant step forward towards our core mission of getting every eligible patient the right test and the right therapy to positively impact their disease outcome."

As of 1000 BST, Diaceutics shares were up 4.33% at 108.50p.









Reporting by Iain Gilbert at Sharecast.com

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Diaceutics Market Data

Currency UK Pounds
Share Price 120.00p
Change Today -0.50p
% Change -0.41 %
52 Week High 134.00
52 Week Low 84.50
Volume 41,899
Shares Issued 84.77m
Market Cap £101.73m
Beta 0.15
RiskGrade 196

Diaceutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
35.56% below the market average35.56% below the market average35.56% below the market average35.56% below the market average35.56% below the market average
54.29% below the sector average54.29% below the sector average54.29% below the sector average54.29% below the sector average54.29% below the sector average
Price Trend
57.99% above the market average57.99% above the market average57.99% above the market average57.99% above the market average57.99% above the market average
83.78% above the sector average83.78% above the sector average83.78% above the sector average83.78% above the sector average83.78% above the sector average
Income Not Available
Growth
20.85% above the market average20.85% above the market average20.85% above the market average20.85% above the market average20.85% above the market average
16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average

Diaceutics Dividends

No dividends found

Trades for 12-Dec-2024

Time Volume / Share Price
11:00 2,500 @ 122.00p
11:00 2,500 @ 122.00p
10:36 6,000 @ 118.00p
09:17 2,000 @ 120.00p
08:16 12,621 @ 119.25p

Diaceutics Key Personnel

CEO Ryan Gerard Keeling
CFO Nick Roberts

Top of Page